Risks of Untreated Hearing Loss
Untreated hearing loss significantly increases mortality risk, accelerates cognitive decline including dementia, and substantially impairs quality of life through depression, social isolation, falls, and functional decline.
Mortality Risk
Untreated hearing loss is associated with increased all-cause mortality (HR: 1.21), cardiovascular mortality (HR: 1.22), and cancer mortality (HR: 1.11) 1. The effect is stronger when hearing loss is measured audiometrically rather than self-reported, and the risk increases progressively over time, with the greatest absolute risk differences observed at 10 years.
Cognitive and Neurological Impact
The most concerning risk is cognitive decline and dementia. The 2024 AAO-HNS guideline emphasizes that untreated age-related hearing loss shows a clear link with cognitive decline, affecting thinking, learning, memory, and problem-solving 2. The mechanisms include:
- Social isolation-related brain changes - hearing loss leads to reduced social support and decreased mental activity (3.0 fewer hours per week per 10 dB of hearing loss) 2
- Structural brain changes - correlation with gray matter atrophy 2
- Cognitive load depletion - significantly depletes cognitive reserves 2
The relative risk for dementia at 5 years is 1.50, with an attributable risk of 3.20 per 100 persons over 10 years 3. Importantly, hearing aid use decreases dementia risk by 8-29% 2, and the ACHIEVE trial showed that in older adults at increased risk for cognitive decline, hearing intervention reduced cognitive decline 2.
Mental Health Consequences
Depression represents a major risk, with 69% of hearing-impaired community-dwelling older adults experiencing depression versus 31% without hearing impairment 2. The relative risk for depression at 5 years is 1.41, with an attributable risk of 6.88 per 100 persons over 10 years 3. This association is particularly strong for late-life depression (onset after age 60) 2.
Safety and Physical Function
Untreated hearing loss doubles the risk of falls in older individuals 2. The 10-year attributable risk for falls is 3.57 per 100 persons 3. Additional safety concerns include:
- Reduced situational awareness and inability to hear warnings 2
- Increased work-related injuries 2
- 87% increased risk of frailty in cross-sectional studies (RR: 1.87) 2
- 31% greater risk for incident disability in women 2
Functional and Social Impact
The guideline specifies that untreated hearing loss causes 2:
- Communication breakdown affecting relationships at home, work, and healthcare settings
- Increased listening effort and fatigue compared to normal-hearing controls 2
- Social isolation regardless of whether treatment is received 2
- Reduced physical activity due to increased cognitive load, walking impairments, reduced gait speed, and safety concerns 2
- Lower ability to complete daily activities around the house or at work 2
Healthcare Utilization and Economic Burden
Untreated hearing loss is associated with 46% higher total healthcare costs ($22,434 more) over 10 years 4. Patients experience:
- 47% more inpatient stays (incidence rate ratio: 1.47) 4
- 44% greater risk for 30-day hospital readmission (RR: 1.44) 4
- Lifetime costs estimated at $70,000 per person for severe hearing loss 2
Quality of Life
Untreated hearing loss significantly reduces quality of life for both individuals and their families 2. Contributing factors include listening effort, fatigue, and lower levels of social, physical, and mental activities. Family members also experience reduced quality of life from communication challenges 2.
Clinical Implications
The 2024 AAO-HNS guideline strongly recommends that clinicians educate patients about these risks, emphasizing that treating hearing loss with properly fitted hearing aids may reduce cognitive decline and dementia risk 2. The evidence supports early identification and treatment, particularly given that the adverse effects compound over time and affect multiple organ systems beyond just auditory function.
Common pitfall: The 2012 USPSTF guideline 5 concluded evidence was insufficient for population screening benefits, but this predates the substantial body of evidence on cognitive decline and mortality. The more recent 2024 AAO-HNS guideline 2 now recommends screening patients aged 50 years and older at healthcare encounters, reflecting the updated understanding of hearing loss's broad health impacts.